Skip to content

Single Use Biliary Drainage Stent V PBD-1031-0711Recalls & reported problems

Olympus Medical Systems Corp. · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 04953170346439), received between Oct 8, 2024 and Oct 8, 2024 — classified as 2 injuries.

The most frequently reported specific device problem is “Migration” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 2 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Migration1

Patient problems

  • Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
  • Hemorrhage/Blood Loss/Bleeding1
  • Obstruction/Occlusion1
  • Peritonitis1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 8, 2024Migration; Migration

    OLYMPUS REVIEWED THE FOLLOWING LITERATURE TITLED "SAFE PERFORMANCE OF TRACK DILATION AND BILE ASPIRATION WITH ERCP CATHETER IN EUS-GUIDED HEPATICOGASTROSTOMY WITH PLASTIC STENTS: A RETROSPECTIVE MULTICENTER STUDY." LITERATURE SUMMARY ABSTRACT OBJECTIVES: ENDOSCOPIC-ULTRASOUND-GUIDED HEPATICOGASTROSTOMY (EUS-HGS) WITH PLASTIC STENT PLACEMENT IS ASSOCIATED WITH A HIGH INCIDENCE OF ADVERSE EVENTS THAT MAY BE REDUCED USING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) CONTRAST CATHETER IN THE TRACK DILATION STEP. IN THIS STUDY, WE EVALUATED THE USEFULNESS OF TRACK DILATION AND BILE ASPIRATION PERFORMED WITH AN ERCP CONTRAST CATHETER IN EUS-HGS WITH PLASTIC STENT PLACEMENT. METHODS: IN A MULTICENTER SETTING, 22 EUS-HGS CASES DILATED WITH AN ERCP CONTRAST CATHETER WERE ANALYZED RETROSPECTIVELY AND COMPARED BETWEEN A BILE ASPIRATION GROUP AND NO BILE ASPIRATION GROUP. RBO WAS DEFINED AS THE RECURRENCE OF OBSTRUCTIVE JAUNDICE AND/OR CHOLANGITIS DUE TO STENT OCCLUSION OR MIGRATION. ADVERSE EVENTS OTHER THAN RBO WERE CATEGORIZED AS POST-PROCEDURE COMPLICATIONS, WHICH INCLUDED BILE LEAKAGE, PERITONITIS, BLEEDING, PERFORATION, PANCREATITIS, CHOLECYSTITIS, ASPIRATION PNEUMONIA, LIVER

    Patient problems: Obstruction/Occlusion

    MAUDE report 20397085 ↗
  • InjuryOct 8, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    OLYMPUS REVIEWED THE FOLLOWING LITERATURE TITLED "SAFE PERFORMANCE OF TRACK DILATION AND BILE ASPIRATION WITH ERCP CATHETER IN EUS-GUIDED HEPATICOGASTROSTOMY WITH PLASTIC STENTS: A RETROSPECTIVE MULTICENTER STUDY." LITERATURE SUMMARY: ABSTRACT OBJECTIVES: ENDOSCOPIC-ULTRASOUND-GUIDED HEPATICOGASTROSTOMY (EUS-HGS) WITH PLASTIC STENT PLACEMENT IS ASSOCIATED WITH A HIGH INCIDENCE OF ADVERSE EVENTS THAT MAY BE REDUCED USING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) CONTRAST CATHETER IN THE TRACK DILATION STEP. IN THIS STUDY, WE EVALUATED THE USEFULNESS OF TRACK DILATION AND BILE ASPIRATION PERFORMED WITH AN ERCP CONTRAST CATHETER IN EUS-HGS WITH PLASTIC STENT PLACEMENT. METHODS: IN A MULTICENTER SETTING, 22 EUS-HGS CASES DILATED WITH AN ERCP CONTRAST CATHETER WERE ANALYZED RETROSPECTIVELY AND COMPARED BETWEEN A BILE ASPIRATION GROUP AND NO BILE ASPIRATION GROUP. RBO WAS DEFINED AS THE RECURRENCE OF OBSTRUCTIVE JAUNDICE AND/OR CHOLANGITIS DUE TO STENT OCCLUSION OR MIGRATION. ADVERSE EVENTS OTHER THAN RBO WERE CATEGORIZED AS POST-PROCEDURE COMPLICATIONS, WHICH INCLUDED BILE LEAKAGE, PERITONITIS, BLEEDING, PERFORATION, PANCREATITIS, CHOLECYSTITIS, ASPIRATION PNEUMONIA, LIVE

    Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; Hemorrhage/Blood Loss/Bleeding; Peritonitis

    MAUDE report 20397083 ↗

Other CATHETER, BILIARY, DIAGNOSTIC devices

All CATHETER, BILIARY, DIAGNOSTIC devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page